When you control the media, you control the story. This NY

New Post Public Reply Private Reply Replies (0) Message Board
Drano
When you control the media, you control the story. This NY Times daily email is laden with easily refuted misinformation.

Quote:
FOUNDER OF GAWKER SUSPECTS LAWSUITS HAVE A COMMON FINANCER [an unsubstantiated claim is being presented as fact] Nick Denton, the founder of Gawker Media, is starting to believe that a lawsuit brought by the wrestler Hulk Hogan might be funded by someone other than Mr. Hogan, Andrew Ross Sorkin writes in the DealBook column. And the aim might be to do something other than simply inflicting financial pain on Gawker.

"My own personal hunch is that it's linked to Silicon Valley, but that's nothing really more than a hunch," Mr. Denton said. "If you're a billionaire and you don't like the coverage of you, and you don't particularly want to embroil yourself any further in a public scandal, it's a pretty smart, rational thing to fund other legal cases."

In recent weeks, several new lawsuits have been brought against Gawker. They are unrelated to Mr. Hogan's case and seem to personally attack certain Gawker writers. [maybe because certain Gawker writers write libelous things, and other Gawker writers do not?] All the new cases, like Mr. Hogan's, were brought by Charles J. Harder, a litigator based in Los Angeles, working on a contingency basis, [how do they know if he's working on a contingency? they don't] who has most likely run up huge legal bills and expenses. ["most likely" -- they don't know that. He's not paying himself, if he IS doing it on contingency, and that's by far the largest part of legal expenses, attorney fees] Mr. Hogan's financial health has been erratic. Gawker said it had already spent as much as $10 million on its side of the case. [Sure they have -- they have to PAY their attorney. Mr. Harder pays himself after the case is over, IF indeed he's taking it on contingency.]

"The answer may be entirely innocent," Mr. Denton said, "but I think in order for people to understand what's going on here, what the stakes are, I think it's important that it be out in public, or at least that he'd be asked the question in public." [so, he doesn't have any basis of fact, but is going to throw accusations around in case it can throw mud on the other side.]

Mr. Harder said, "I do not discuss the finances of my clients, including any financial arrangements they have with my firm. This applies to all clients." [So this guy trying to say it's a big plot has absolutely NO basis for the claim that all the clients are being taken on contingency.]

It would not be the first time that lawsuits had been funded for reasons beyond strict economics. [That, of course, is assuming that the allegation is true -- for which there is no basis.] Kenneth G. Langone, the co-founder of Home Depot and former director of the New York Stock Exchange, helped fund Maurice R. Greenberg's lawsuit against the United States government over the bankruptcy of the American International Group, which was viewed as being as much as about money as about principle.

Mr. Denton's suspicions increased after Mr. Hogan's legal team abruptly dropped one of the claims, for "negligent infliction of emotional distress," from its case - the one that required Gawker's insurance company to pay for its defense.

Legal experts said that it was particularly unusual [no it is not] for a plaintiff using a lawyer being paid on a contingency basis [but they don't KNOW if he's being paid on a contingency, they're just taking an unsubstantiated claim by an opponent and building a house of cards on that] not only to turn down settlement offers, but also to pursue a strategy that prevented an insurance company from being able to contribute to a settlement. [There is, of course, an alternate theory, which is a commonly-used strategy: remove the insurance company's financial payment OF THE DEFENDANT'S LAWYERS, so that it is so expensive for Gawker to defend, that they'll just pay a bigger settlement to the plaintiff instead.)

"I think it's in the public's interest and the media interest for the motives of people on both sides to be out there," Mr. Denton said.[so why isn't the NY Times making it clear that this is a load of BS by a panicked defendant?]

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CelluPro Earns Global Recognition with EXCiPACT Certification

Updated Category News Views 2

Breaking New Ground with EXCiPACT Certification Here's a tale unfolding in the high-stakes world of biotechnology—CelluPro, a standout in cell culture media, just snagged the EXCiPACT™ certification. This isn't just some fancy plaque for the wall. It's a stamp of approval that screams reliability in the global biomanufacturing supply scene. Why This Certification...

Continue Reading
Aluminum Refractory Market to Hit $2.73B by 2031

Updated Category News Views 5

Riding the Aluminum Refractory Wave to 2031 Look, when you want to throw some cash in a market that's gaining steam, aluminum refractory materials might not be your first pick. But here's the thing: it's charging ahead to a cool $2.73 billion by 2031. And if you're keeping tabs on the likes of RHI Magnesita and Calderys, this is a sector that deserves a once-over. What...

Continue Reading
Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Updated Category News Views 3

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Continue Reading
Thermoplastic Polyimide: A $0.86 Billion Market by 2032

Updated Category News Views 1

It's not often you get hyped about a compound with a name like 'thermoplastic polyimide,' but hold your horses—this isn't just any chemical. If you're watching markets with a sharp eye, you’ll see this thing estimated at $0.56 billion in 2026, gunning for a hefty $0.86 billion by 2032. We're talking about a solid 7.4% CAGR ride here folks, according to new data from...

Continue Reading
Nurminen Logistics Doubles Sweden–Italy Rail Capacity

Updated Category News Views 6

Nurminen Logistics Betting Big on Rail Expansion Feeling the pulse of the logistics world is much like trying to catch lightning in a bottle, but Nurminen Logistics seems to have found its rhythm. They're ramping up their services between Sweden and Italy, leveraging rail to push the envelope. Come October, they're doubling down from one to two weekly departures, giving...

Continue Reading
Early Orders Key for Custom Kids' Gifts This Season

Updated Category News Views 1

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Continue Reading
Indiana Fire Safety: The Importance of Regular Inspections

Updated Category News Views 3

Everybody thinks of fire extinguishers as those red cans hanging quietly on walls, but there's more to them than meets the eye. In Central Indiana, these devices are a literal lifeline, and neglecting their upkeep is playing with fire—literally. What Makes Monthly Checks a Big Deal? Fire extinguishers aren't just there for decoration. They're critical safety gear. This...

Continue Reading
U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 9

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
FOTON Accelerates Global Push with European Focus

Updated Category News Views 4

The Road to Global Dominance Ever feel like someone’s racing past you while others try to catch up? That’s FOTON in the relentless world of commercial vehicles. This juggernaut of a company isn't just satisfied with leading the pack; they’ve got their eyes set on redefines the game, especially with their new moves in Europe. A Shift in Strategy Right now, the...

Continue Reading
Huayan Robotics Hits IMTS 2026 with Cutting-Edge Tech

Updated Category News Views 2

Unveiling Robotics Prowess at IMTS 2026 Every two years, the world of manufacturing gathers at the International Manufacturing Technology Show (IMTS), and this time, the spotlight is on Huayan Robotics. With the event drawing over 90,000 professionals, everybody with a finger on the pulse of intelligent manufacturing will be keen to see what Huayan has up its sleeve. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Recycling Equipment: Market Growth Insights

Updated Category News Views 105

The Growing Recycling Equipment Market The Recycling Equipment Market is on a remarkable trajectory, with expectations to soar from USD 29.46 billion in 2023 to USD 48.07 billion by 2032. This promising growth reflects a compound annual growth rate (CAGR) of 5.59% between 2024 and 2032. A global awakening to environmental issues is driving industries and governments alike...

Continue Reading
Callinex Mines Expands Exploration Efforts at Pt. Leamington

Updated Category News Views 99

Callinex Mines Receives Exploration Permit for Point Leamington Project Callinex Mines Inc., a prominent player in the base and precious metals sector, has recently secured a two-year exploration permit for its Pt. Leamington Project. This exciting development comes as the company aims to enhance its mineral resource base, specifically targeting the rich deposits of gold,...

Continue Reading
Exploring Oncology's Rapid Evolution and Oncolytics' Potential

Updated Category News Views 102

Oncology Approvals and Their Impact The landscape of oncology treatment is undergoing a remarkable transformation. Regulatory bodies like the FDA are not only approving new drugs but actively reshaping the future of cancer therapies. Recently, we've witnessed a surge in approvals, with over 50 new oncology treatments being authorized, signifying a pivotal change in...

Continue Reading
Oportun Successfully Launches $425 Million Asset-Backed Notes

Updated Category News Views 139

Oportun's Latest $425 Million Financing Success Oportun has recently achieved a significant milestone by successfully issuing $425 million in asset-backed securities. This accomplishment highlights the company's continual growth and robust position in the financial services sector. Understanding the Transaction This transaction comprised revolving fixed-rate notes backed...

Continue Reading
Steep Decline in CEO Confidence Signals Economic Challenges

Updated Category News Views 206

Significant Drop in CEO Confidence in Recent Survey The Conference Board recently reported a dramatic decline in the Measure of CEO Confidence, reflecting a stark shift in the sentiment among business leaders. In Q2 2025, the metric plunged by 26 points to a mere 34, marking the lowest level since late 2022. This decline is notable as it represents the most significant...

Continue Reading